141 related articles for article (PubMed ID: 11136551)
1. Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia.
Conley YP; Finegold DN; Peters DG; Cook JS; Oppenheim DS; Ferrell RE
Mol Genet Metab; 2000 Dec; 71(4):591-8. PubMed ID: 11136551
[TBL] [Abstract][Full Text] [Related]
2. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia.
Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S
J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719
[TBL] [Abstract][Full Text] [Related]
3. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.
Pearce SH; Williamson C; Kifor O; Bai M; Coulthard MG; Davies M; Lewis-Barned N; McCredie D; Powell H; Kendall-Taylor P; Brown EM; Thakker RV
N Engl J Med; 1996 Oct; 335(15):1115-22. PubMed ID: 8813042
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor.
Hu J; Mora S; Weber G; Zamproni I; Proverbio MC; Spiegel AM
J Bone Miner Res; 2004 Apr; 19(4):578-86. PubMed ID: 15005845
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis.
Felderbauer P; Hoffmann P; Klein W; Bulut K; Ansorge N; Epplen JT; Schmitz F; Schmidt WE
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):31-4. PubMed ID: 15662592
[TBL] [Abstract][Full Text] [Related]
6. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation.
Pollak MR; Brown EM; Estep HL; McLaine PN; Kifor O; Park J; Hebert SC; Seidman CE; Seidman JG
Nat Genet; 1994 Nov; 8(3):303-7. PubMed ID: 7874174
[TBL] [Abstract][Full Text] [Related]
8. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism.
Canaff L; Zhou X; Mosesova I; Cole DE; Hendy GN
Hum Mutat; 2009 Jan; 30(1):85-92. PubMed ID: 18712808
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
10. A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor.
Nagase T; Murakami T; Tsukada T; Kitamura R; Chikatsu N; Takeo H; Takata N; Yasuda H; Fukumoto S; Tanaka Y; Nagata N; Yamaguchi K; Akatsu T; Yamamoto M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2681-7. PubMed ID: 12050233
[TBL] [Abstract][Full Text] [Related]
11. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Pidasheva S; D'Souza-Li L; Canaff L; Cole DE; Hendy GN
Hum Mutat; 2004 Aug; 24(2):107-11. PubMed ID: 15241791
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain.
Hu J; Mora S; Colussi G; Proverbio MC; Jones KA; Bolzoni L; De Ferrari ME; Civati G; Spiegel AM
J Bone Miner Res; 2002 Aug; 17(8):1461-9. PubMed ID: 12162500
[TBL] [Abstract][Full Text] [Related]
13. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
[TBL] [Abstract][Full Text] [Related]
14. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
Pearce SH; Trump D; Wooding C; Besser GM; Chew SL; Grant DB; Heath DA; Hughes IA; Paterson CR; Whyte MP
J Clin Invest; 1995 Dec; 96(6):2683-92. PubMed ID: 8675635
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
[TBL] [Abstract][Full Text] [Related]
16. Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor.
Tan YM; Cardinal J; Franks AH; Mun HC; Lewis N; Harris LB; Prins JB; Conigrave AD
J Clin Endocrinol Metab; 2003 Feb; 88(2):605-10. PubMed ID: 12574188
[TBL] [Abstract][Full Text] [Related]
17. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia.
Lienhardt A; Garabédian M; Bai M; Sinding C; Zhang Z; Lagarde JP; Boulesteix J; Rigaud M; Brown EM; Kottler ML
J Clin Endocrinol Metab; 2000 Apr; 85(4):1695-702. PubMed ID: 10770217
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome.
Vezzoli G; Arcidiacono T; Paloschi V; Terranegra A; Biasion R; Weber G; Mora S; Syren ML; Coviello D; Cusi D; Bianchi G; Soldati L
J Nephrol; 2006; 19(4):525-8. PubMed ID: 17048213
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
[TBL] [Abstract][Full Text] [Related]
20. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.
Watanabe T; Bai M; Lane CR; Matsumoto S; Minamitani K; Minagawa M; Niimi H; Brown EM; Yasuda T
J Clin Endocrinol Metab; 1998 Jul; 83(7):2497-502. PubMed ID: 9661634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
